Apollo to Buy $3.4 Billion Stake in Bayer Contraceptives Business

The asset-management firm agreed to buy a minority stake in Bayer’s long-acting reversible contraceptives business.

You are being sent to the original publisher. FX Radar keeps this reference for market context and source discovery.